Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of ursodeoxycholic acid on neonatal indirect jaundice
IRCT20171124037615N1Phase 3Completed
- Sponsor
- Zabol University of Medical Sciences
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ursodeoxycholic acid in hyperbilirubinemia, sponsored by Zabol University of Medical Sciences. Started Jan 2017; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
hyperbilirubinemia
Beyond the preview
Go deeper on IRCT20171124037615N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171124037615N1.